ES2145003T3 - Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano. - Google Patents

Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano.

Info

Publication number
ES2145003T3
ES2145003T3 ES92305491T ES92305491T ES2145003T3 ES 2145003 T3 ES2145003 T3 ES 2145003T3 ES 92305491 T ES92305491 T ES 92305491T ES 92305491 T ES92305491 T ES 92305491T ES 2145003 T3 ES2145003 T3 ES 2145003T3
Authority
ES
Spain
Prior art keywords
dioxabiciclo
octano
derivative
composition containing
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92305491T
Other languages
English (en)
Inventor
Ayako Nakabayashi
Yoshinori Kitagawa
Kengo Akimoto
Michihiro Sugano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15345304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2145003(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2145003T3 publication Critical patent/ES2145003T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UNA COMPOSICION COSMETICA, FARMACEUTICA, PARA BEBER Y ALIMENTICIA DE UN ADITIVO ALIMENTARIO QUE CONTIENE UN DERIVADO DE DIOXABICICLO[3.3.O]OCTANO REPRESENTADO POR LA SIGUIENTE FORMULA GENERAL (I): EN DONDE R1, R2, R3, R4, R5 Y R6 REPRESENTAN INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO QUE TIENE DE 1 A 3 ATOMOS DE CARBONO, O R1 Y R2 Y/O R4 Y R5 JUNTOS FORMAN UN GRUPO METILENO O UN GRUPO ETILENO, Y N, M Y LANDA SON 0 O 1; Y UN ANTIOXIDANTE.
ES92305491T 1991-06-15 1992-06-15 Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano. Expired - Lifetime ES2145003T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14371591A JP3283274B2 (ja) 1991-06-15 1991-06-15 新規組成物

Publications (1)

Publication Number Publication Date
ES2145003T3 true ES2145003T3 (es) 2000-07-01

Family

ID=15345304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92305491T Expired - Lifetime ES2145003T3 (es) 1991-06-15 1992-06-15 Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano.

Country Status (10)

Country Link
US (1) US5637610A (es)
EP (1) EP0519673B1 (es)
JP (1) JP3283274B2 (es)
AT (1) ATE192038T1 (es)
CA (1) CA2071248C (es)
DE (1) DE69230958T2 (es)
DK (1) DK0519673T3 (es)
ES (1) ES2145003T3 (es)
PT (1) PT519673E (es)
SG (1) SG47437A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500937A (ja) * 1994-02-25 1998-01-27 ニュー イングランド ディーコネス ホスピタル コーポレイション セサミン系リグナンの抗炎症及び感染防護効果
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
DK0782827T3 (da) * 1995-07-04 2004-02-09 Suntory Ltd Anvendelse af et afbalanceringsmiddel til omega-6- og omega-3-umættede fedtsyrer
JPH11246427A (ja) * 1998-03-04 1999-09-14 Kadoya Sesami Mills Inc 糖・脂質代謝活性化剤
US7005446B1 (en) * 1999-04-20 2006-02-28 Alcon Manufacturing, Ltd. Use of AP-1 activators to treat glaucoma and ocular hypertension
RU2203077C2 (ru) * 2000-02-14 2003-04-27 Сибирский государственный медицинский университет Способ получения средства, обладающего антиоксидантной активностью
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
KR100457732B1 (ko) * 2002-07-20 2004-11-17 주식회사 렉스진바이오텍 광학합성의 비대칭 푸로푸란리그난 화합물의 신규 제조방법
CN101849935B (zh) * 2004-12-28 2011-09-28 三得利控股株式会社 芝麻素/异芝麻素组合物
US20060182828A1 (en) * 2005-02-17 2006-08-17 Colman John S Methods of reducing lipid peroxidation and achieving related health benefits by the administration of tocopherol and sesame lignans
CA2603347C (en) 2005-03-31 2014-06-17 Suntory Limited Oil-in-water emulsions of lignans that exhibit improved absorption rate
KR101451438B1 (ko) * 2006-03-15 2014-10-15 산토리 홀딩스 가부시키가이샤 리보플라빈과 세사민류를 함유하는 조성물
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds
AU2007305614B2 (en) 2006-10-04 2012-08-23 Suntory Holdings Limited O/W/O emulsion containing lignan compounds and composition containing the same
EP3342409A1 (en) * 2007-03-15 2018-07-04 Suntory Holdings Limited Anti-fatigue agent
JP5794761B2 (ja) * 2007-09-19 2015-10-14 サントリーホールディングス株式会社 セサミン類及びビタミンｅを含有する抗疲労剤
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
JP5348805B2 (ja) * 2011-08-18 2013-11-20 かどや製油株式会社 水分散性セサミン類粉末の製造方法
KR20130046115A (ko) * 2011-10-27 2013-05-07 (주)아모레퍼시픽 시링가레시놀을 포함하는 혈관 노화 억제용 조성물
JP7366991B2 (ja) * 2019-02-28 2023-10-23 株式会社えがお 体重増加抑制・低減用組成物
WO2021006822A1 (en) * 2019-07-08 2021-01-14 Chiangmai University Pharmaceutical compositions having synergistic effects of natural extracts for cancer treatment undergoing chemotherapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA828513B (en) * 1981-11-24 1983-12-28 Shelleden Products Ltd Pharmaceutical preparations and compositions
US4427694A (en) * 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
JPS6041611A (ja) * 1983-08-17 1985-03-05 Sankyo Co Ltd 血中脂質低下剤
JPS6043365A (ja) * 1983-08-19 1985-03-07 M S C:Kk 新規な食品
JPS60197621A (ja) * 1984-03-19 1985-10-07 Hohnen Oil Co Ltd コレステロ−ル低下剤
JPS60224629A (ja) * 1984-04-23 1985-11-09 Kao Corp 生体内過酸化脂質生成抑制剤組成物
JPS61212518A (ja) * 1985-03-19 1986-09-20 Nippon Paint Co Ltd 血液凝固促進剤
JPS62581A (ja) * 1985-06-26 1987-01-06 Takemoto Oil & Fat Co Ltd フエノ−ル性天然抗酸化性物質の製造方法
JPS6243365A (ja) * 1985-08-20 1987-02-25 Honda Motor Co Ltd トラクタの前後輪操舵装置
JPS6244145A (ja) * 1985-08-22 1987-02-26 Horiuchi:Kk 抗肥満食品
JPH0651632B2 (ja) * 1985-09-05 1994-07-06 昭和産業株式会社 降コレステロ−ル剤
JPH0787763B2 (ja) * 1986-08-07 1995-09-27 日清製油株式会社 食品用品質保持剤
JPH01202278A (ja) * 1988-02-05 1989-08-15 Nisshin Oil Mills Ltd:The 食品用品質保持剤
JPH02138120A (ja) * 1988-11-21 1990-05-28 Nippon Kayaku Co Ltd リポキシゲナーゼ阻害剤
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
JP3001589B2 (ja) * 1989-07-21 2000-01-24 サントリー株式会社 リグナン類含有飲食物
ES2235205T3 (es) * 1989-07-21 2005-07-01 Suntory Limited Capsula que contiene compuestos de dioxabiciclo (3.3.0)octano.
JP3183664B2 (ja) * 1990-10-22 2001-07-09 サントリー株式会社 コレステロール及び胆汁酸の代謝阻害剤
JPH04290822A (ja) * 1991-03-15 1992-10-15 Nippon Oil & Fats Co Ltd アレルギー予防薬および食品

Also Published As

Publication number Publication date
DE69230958T2 (de) 2000-10-05
JP3283274B2 (ja) 2002-05-20
SG47437A1 (en) 1998-04-17
DE69230958D1 (de) 2000-05-31
DK0519673T3 (da) 2000-08-07
US5637610A (en) 1997-06-10
CA2071248A1 (en) 1992-12-16
CA2071248C (en) 2005-07-19
JPH04368326A (ja) 1992-12-21
EP0519673A1 (en) 1992-12-23
EP0519673B1 (en) 2000-04-26
PT519673E (pt) 2000-09-29
ATE192038T1 (de) 2000-05-15

Similar Documents

Publication Publication Date Title
ES2145003T3 (es) Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano.
EP0421634A3 (en) Bis(3,4-dialkylbenzylidene) sorbitol acetals and compositions containing same
AU716372C (en) Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier
WO1987006226A3 (en) Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
GB2185252B (en) Triazole derivatives
EP0429681A4 (en) Intermediate for 2-alkynyladenosine synthesis, production of said intermediate, production of 2-alkynyladenosine from said intermediate, and stable 2-alkynyladenosine derivative
ES2087252T3 (es) Uso de derivados de dioxabiciclo(3.3.0)octano para la preparacion de un medicamento para inhibir el metabolismo del colesterol.
AU1739092A (en) 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
IL90724A0 (en) Novel esters and pharmaceutical compositions containing same
NZ230128A (en) Dibenzooxepine-pyridinium and -pyrrolo derivatives and pharmaceutical compositions
SE8600046D0 (sv) Use of an ester compound as a temporary bactericide and product containing said ester compound
AU8460791A (en) Compound, preparation and use
SI0681788T1 (en) Dioxabicyclo(3.3.0) octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
AU4953997A (en) New histidine derivatives, preparation process, and their use as free antiradical agents
AU637217B2 (en) Wood preservative compositions
AU4726089A (en) Benzoxazepine derivative
AU2474488A (en) Photochromatic composition and photochromatic articles which contain it
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
GB1530118A (en) Acylcyclohexenes and their use in perfumery compositions
ES8606319A1 (es) Un metodo para producir un derivado de acido ascorbico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 519673

Country of ref document: ES